CI:NYE-Cigna Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 320.94

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.06M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-17 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 415.38B
ELV Elevance Health Inc

N/A

USD 99.57B
CNC Centene Corp

N/A

USD 30.11B
MOH Molina Healthcare Inc

N/A

USD 17.62B
OSCR Oscar Health Inc

N/A

USD 4.46B
NEUE NeueHealth Inc

N/A

USD 0.06B
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CI

AILV 4.45 % 0.00 %

N/A

N/A
MFSV MFS Active Value ETF 3.32 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
BUSA 2023 EFT Series Trust - B.. 2.44 % 0.00 %

N/A

USD 0.23B
JAVA JPMorgan Active Value ETF 1.65 % 0.00 %

N/A

USD 3.01B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Quantitative Stra.. 1.53 % 0.00 %

N/A

N/A
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
FLDZ Listed Funds Trust 0.48 % 0.00 %

N/A

USD 3.65M
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.10B
BOUT Innovator ETFs Trust - In.. 0.00 % 0.80 %

N/A

USD 0.01B
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

N/A

USD 1.79B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

N/A
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 9.47M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.24B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.18B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 0.00 % 0.00 %

N/A

CAD 3.64M
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.08B
FFND The Future Fund Active ET.. 0.00 % 0.00 %

N/A

USD 0.06B
NTZG 0.00 % 0.00 %

N/A

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
IFSW:SW iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.60B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.22% 78% C+ 91% A-
Dividend Return 0.55% 80% B- 23% F
Total Return 16.77% 78% C+ 91% A-
Trailing 12 Months  
Capital Gain -5.25% 78% C+ 30% F
Dividend Return 1.69% 80% B- 35% F
Total Return -3.56% 78% C+ 27% F
Trailing 5 Years  
Capital Gain 65.85% 83% B 62% D
Dividend Return 10.60% 50% F 25% F
Total Return 76.45% 83% B 58% F
Average Annual (5 Year Horizon)  
Capital Gain 11.07% 78% C+ 73% C
Dividend Return 12.74% 89% A- 72% C
Total Return 1.67% 80% B- 39% F
Risk Return Profile  
Volatility (Standard Deviation) 22.50% 67% D+ 44% F
Risk Adjusted Return 56.60% 100% F 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:

There is nothing we particularly dislike